NCT05674981View on ClinicalTrials.gov

To Evaluate the Beneficial Effect of Probiotics on DKD Patients and the Role of Gut Microbiota Modulation

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Diabetic Kidney Disease
Interventions
DIETARY_SUPPLEMENT

Probiotic group

Two-strain probiotic supplement includes Lactobacillus reuteri ADR-1 (alive) and Lactobacillus rhamnosus GM-020 ( alive).

OTHER

Placebo group

Same additives to Probiotic group but replace probiotics with corn starch and Maltodextrin.

Trial Locations (1)

402

RECRUITING

Chung Shan Medical University Hospital, Taichung

All Listed Sponsors
collaborator

Chung Shan Medical University

OTHER

lead

GenMont Biotech Incorporation

INDUSTRY